| __timestamp | Halozyme Therapeutics, Inc. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79696000 | 21226345 |
| Thursday, January 1, 2015 | 93236000 | 87718074 |
| Friday, January 1, 2016 | 150842000 | 93831530 |
| Sunday, January 1, 2017 | 150643000 | 79419009 |
| Monday, January 1, 2018 | 150252000 | 132166913 |
| Tuesday, January 1, 2019 | 140804000 | 89124838 |
| Wednesday, January 1, 2020 | 34236000 | 65782137 |
| Friday, January 1, 2021 | 35672000 | 88845513 |
| Saturday, January 1, 2022 | 66607000 | 134715000 |
| Sunday, January 1, 2023 | 76363000 | 180142000 |
| Monday, January 1, 2024 | 79048000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) is the lifeblood of innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Halozyme Therapeutics, Inc. have been at the forefront of this transformative journey. From 2014 to 2023, these companies have shown remarkable dedication to advancing medical science, with R&D expenses reflecting their commitment.
Intra-Cellular Therapies, Inc. has seen a staggering 750% increase in R&D spending, peaking in 2023. This surge underscores their relentless pursuit of groundbreaking therapies. Meanwhile, Halozyme Therapeutics, Inc. experienced a more modest 4% growth, with notable fluctuations, particularly in 2016 and 2017, when their R&D expenses reached their zenith.
These trends highlight the dynamic nature of biotech investments, where strategic R&D allocation can be the key to unlocking future medical breakthroughs.
Eli Lilly and Company or Halozyme Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Bio-Techne Corporation vs Halozyme Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Madrigal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Halozyme Therapeutics, Inc. and Iovance Biotherapeutics, Inc.